Comparison of the effects of bischolylglycinatechloro-platinum (II) versus cisplatin on liver regeneration after partial hepatectomy

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3555-3563

  Herrera, Maria C ^a   Palomero, Maria F ^a   Macias, Rocio I R ^a   Serrano, Maria A ^a   Marin, Jose J G ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bile acid; Cancer; Chemotherapy; Glycocholate; Metal; Pt(II); Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BISCHOLYLGLYCINATE CHLOROPLATINUM (II); CISPLATIN; CISPLATIN DERIVATIVE; GLYCOCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RECURRENCE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; DRUG TISSUE LEVEL; KIDNEY; LIVER; LIVER CANCER; LIVER CELL CULTURE; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; SURVIVAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; LIVER REGENERATION; MALE; MICE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0031730807     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tamura J, Tanaka J, Fujita K, Yoshida M, Kasamatsu T, Arii S, Tobe T: Effect of anticancer agents on cell cycle of regenerating hepatocytes in rats. J Surg Res 53: 218-226, 1992.
2. Fortner J, Silva JS, Golbey RB, Maclean BJ: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Treatment by hepatic resection. Ann of Surg 199: 306-316, 1984.
3. August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Schneider PD: Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 201: 210-218, 1985.
4. Patt VZ, McBride CM, Ames FC, Claghorn L, Cleary KR, Boddi AW, Charnsangavej C, Mavligit GM: Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59: 867-873, 1987.
5. Locher PJ, Einhorn LH: Cisplatin. Ann Int Med 100: 704-713, 1984.
6. Bradner WT, Rose WC, Huftalen JB: Antitumor activity of platinum analogs. In: Prestayko AW, Crooke ST, Carter SK, eds. Cisplatin: Current Status and New Developments. New York: Academic Press 171-182, 1980.
7. Bignami P, Doci R, Montalto F, Fissi S, Dibartolomeo M, Gennari L: Feasibility of intraportal chemotherapy with fluorouracil and folinic acid immediately after hepatic resection for colorectal metastases. Tumori 81: 96-101, 1995.
8. Hofmann AF: Biliary secretion and excretion -The hepatobiliary component of the enterohepatic circulation of bile acids. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York: Raven Press 1555-1576, 1994.
9. Kramer W, Wess G: Bile acid transport systems as pharmaceutical targets. Eur J Clin Invest 26: 715-732, 1996.
10. Marin JJG, Herrera MC, Palomero MF, Macias RIR, Monte MJ, El-Mir MY, Villanueva GR: Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum(II). J Hepatol 25: 417-425, 1997.
11. Criado JJ, Herrera MC, Palomero MF, Medarde M, Rodriguez E, Marin JJG: Synthesis and characterization of a new bile acid and platinum(II) complex with cytostatic activity J Lipid Res 38: 1022-1032, 1997.
12. Berry MN, Edward SAM, Barrit GJ: Isolated hepatocytes: Preparation, properties and applications. Amsterdam, Elsevier 1991.
13. Higgins GF, Anderson RM: Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Archs Path 12: 186-202, 1931.
14. Barbero ER, Herrera MC, Monte MJ, Serrano MA, Marin JJG: Role of amidation in bile acid effect on DNA synthesis by regenerating mouse liver. Am J Physiol 31: G1051-G1059, 1995.
15. Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
16. Jendrassik L, Grof P: Vereinfachte photometrische methoden zur bestimmung des blutbilirubins. Biochem Z 297: 81-89, 1938.
17. Kunst A, Draeger B, Ziegehorn J: Colorimetric methods with glucose oxidase and peroxidase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Weinheim: Verlag Chemie 178-185, 1983.
18. Marin JJG, Herrera MC, Palomero MF, Macias RIR, Monte MJ, Villanueva GR, El-Mir MY, Serrano MA, Criado JJ: In vivo distribution, toxicity and cytostatic capacity of platinated bile acid analogs [Abstract]. Hepatology 24: 372A, 1996.
19. Marin JJG, Criado JJ, Palomero MF, Herrera MC, Macias RIR, Monte MJ, Villanueva GR, El-Mir MY, Serrano MA: Platinated bile acids as cytostatic drugs. [Abstract]. Hepatology 24: 542A, 1996.
20. Von Dippe P, Levy D: Expression of the bile acid transport protein during liver development and in hepatoma cells. J Biol Chem 265: 5942-5945, 1990.
21. Marchegiano P, Carubbi F, Tiribelli C, Amarri S, Stebel M, Lunazzi GC, Levy D, Bellentani S: Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins. Biochem Biophys Res Commun 183: 1203-1208, 1992.
22. Kullak-Ublick GA, Beuers U, Paumgartner G: Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells. Hepatology 23: 1053-1060, 1996.
23. Bernal SD, Speak JA, Boeheim K, Dreyfuss AI, Wright JE, Teicher BA, Rosowsky A, Tsao SW, Wong YC: Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum. Mol Cell Biochem 95: 61-70, 1990.
24. Andrews PA, Howell SB: Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43, 1990.